|
|
Post by mnkdfann on Jan 10, 2020 18:10:34 GMT -5
A $2B offer today wouldn't take 60 seconds to reject. With pending UTHR, RLS, pediatric approval, SOC improvement likely, increased CGM use, climbing Afrezza sales and other hinted molecules in the pipeline, the company's future and valuation potential is far brighter. IDK, but I doubt that. I think enough share holders would be willing to sell now for 6 or 7x today's share price (which is what a $2B offer amounts to, more or less). If the Board rejected the offer, I think external pressure would be brought to bear. Think HfM times 1000. |
|
|
|
Post by awesomo on Jan 10, 2020 18:12:53 GMT -5
A $2B offer today wouldn't take 60 seconds to reject. With pending UTHR, RLS, pediatric approval, SOC improvement likely, increased CGM use, climbing Afrezza sales and other hinted molecules in the pipeline, the company's future and valuation potential is far brighter. A $2B offer for MannKind right now would be the highest acquisition premium ever in biopharma (average premium is 35-40%), it would take 1 second to accept. |
|
|
|
Post by akemp3000 on Jan 10, 2020 18:20:27 GMT -5
IDK either but it's fun speculating. I honestly suspect a $2B offer would jump start a bidding war that would escalate. Other large BPs would not want one giant BP with money to promote TS and all the potential associated with it. Let's hope we all get to see the illusive $2B offer and what happens next. Now that would light up this board. As for HFM, 1000x nothing is still nothing. I really like their passion but believe it's a non-starter that will be gone before the next SHM.
There's nothing average about Mannkind. As Nate has said, this is the most undervalued stock in the past several decades. I look forward to seeing him proven right.
|
|
|
|
Post by wgreystone on Jan 10, 2020 18:25:52 GMT -5
IDK either but it's fun speculating. I honestly suspect a $2B offer would jump start a bidding war that would escalate. Other large BPs would not want one giant BP with money to promote TS and all the potential associated with it. Let's hope we all get to see the illusive $2B offer and what happens next. Now that would light up this board. As for HFM, 1000x nothing is still nothing. I really like their passion but believe it's a non-starter that will be gone before the next SHM. There's nothing average about Mannkind. As Nate has said, this is the most undervalued stock in the past several decades. I look forward to seeing him proven right. Undervalue or not depends on if the company can sell Afrezza. So far they haven't shown people they could. That's why change may need to be made to this company. |
|
|
|
Post by awesomo on Jan 10, 2020 18:31:40 GMT -5
There's nothing average about Mannkind. As Nate has said, this is the most undervalued stock in the past several decades. I look forward to seeing him proven right. If it's that undervalued, why doesn't Kendall, Castagna, and company buy shares on the open market? Why do a lot of people on this board apparently own more shares than our Chief Medical Officer? |
|
|
|
Post by sayhey24 on Jan 10, 2020 18:43:06 GMT -5
Much ad-do about nothing. Typical of the last 10 years of hyper boil. Total madness for : A drug not covered by insurance. A drug dropped by a partner because it would not sell. So very very sad that the lemming affect persists with posts after posts about nothing at all of any consequence. Or you could say a drug that is covered by some insurance and that coverage increases each year. A drug recovered from a lousy partner that didn't want it and didn't sell it correctly. Maybe this undervalued company is starting to wiggle its way away from all the chains of the shorts. Who makes you an expert on gauging sadness? I am in the camp that MNKD is finally reaching critical mass. Prior to approval things were pretty predictable based on PDUFA dates and approval versus the CRL. After approval I expected critical mass to be reached after about 3 years of clinical use to determine what lung issues were observed. The Sanofi mess added a year so I was thinking by 2019 things would start coming together. It looks like I was a little too optimistic but 2020 could be the real deal. We all know the story; UT; RLS; TS; and of course the holy grail in diabetes treatment, afrezza. IMO, DXCM with a $22B market cap does not have half the potential of MNKD. What I can tell you is thats more than the current $1.50 pps. Once the kids start using afrezza its off to the moon. |
|
|
|
Post by wgreystone on Jan 10, 2020 18:47:10 GMT -5
Valuation for small companies like MNKD really not depends on real earning (most don't have earning yet) but rather on how much hope the company can give to investors. Obviously, the company can't provide much hope based on past performance and that's why SP stuck at this low level for so long. Hope can be brought in by accelerating sales growth, management change, strategic change like seeking potential buyers, etc.
|
|
|
|
Post by radgray68 on Jan 10, 2020 19:03:55 GMT -5
Shorts sometimes seem to let up selling pressure a month or so before earnings calls. My thoughts are, they can let it float up to make more slamming the stock after conference calls, whether we've had good news or not. Seem to always see a couple of negative headlines to go with it. Warrants still in play so I don't expect to go much further without a surprise announcement of some sorts. And, I hate to bring it up, but, we do face a possible share count increase at annual shareholder meeting within 6 months, so why not let the price float up a little? Make more money? Just spitballing here.
On a side note, but kinda related, I sold most of my trading shares today that were purchased between 1.15 and 1.21. Y'all should be cashing in a little by trading some shares too. I used to hold back because I didn't want to miss out on the big announcement that was always just around the corner. Bought some out of the money leap options(1 year out) to cover my trading shares so if I get caught selling too soon, I always have my core and only give up the first few dollars and the purchase price of the options. Something to think about. Not for the timid, though.
Volatility can be your best friend, believe it or not.
|
|
|
|
Post by falconquest on Jan 10, 2020 19:20:24 GMT -5
Shorts sometimes seem to let up selling pressure a month or so before earnings calls. My thoughts are, they can let it float up to make more slamming the stock after conference calls, whether we've had good news or not. Seem to always see a couple of negative headlines to go with it. Warrants still in play so I don't expect to go much further without a surprise announcement of some sorts. And, I hate to bring it up, but, we do face a possible share count increase at annual shareholder meeting within 6 months, so why not let the price float up a little? Make more money? Just spitballing here. On a side note, but kinda related, I sold most of my trading shares today that were purchased between 1.15 and 1.21. Y'all should be cashing in a little by trading some shares too. I used to hold back because I didn't want to miss out on the big announcement that was always just around the corner. Bought some out of the money leap options(1 year out) to cover my trading shares so if I get caught selling too soon, I always have my core and only give up the first few dollars and the purchase price of the options. Something to think about. Not for the timid, though. Volatility can be your best friend, believe it or not. Man, if you can make a buck on this stock I would say go for it! Very few have. |
|
|
|
Post by sportsrancho on Jan 10, 2020 20:12:37 GMT -5
Somebody put an extra spike in the Kool-Aid, in my opinion the bottom line is MC needs another deal from United pronto.
|
|
|
|
Post by buyitonsale on Jan 10, 2020 20:49:33 GMT -5
More investors are now doing what I have been doing for the last 5 years - buying and holding shares and ignoring all negativity along the way...
|
|
|
|
Post by sportsrancho on Jan 10, 2020 20:49:45 GMT -5
Shorts sometimes seem to let up selling pressure a month or so before earnings calls. My thoughts are, they can let it float up to make more slamming the stock after conference calls, whether we've had good news or not. Seem to always see a couple of negative headlines to go with it. Warrants still in play so I don't expect to go much further without a surprise announcement of some sorts. And, I hate to bring it up, but, we do face a possible share count increase at annual shareholder meeting within 6 months, so why not let the price float up a little? Make more money? Just spitballing here. On a side note, but kinda related, I sold most of my trading shares today that were purchased between 1.15 and 1.21. Y'all should be cashing in a little by trading some shares too. I used to hold back because I didn't want to miss out on the big announcement that was always just around the corner. Bought some out of the money leap options(1 year out) to cover my trading shares so if I get caught selling too soon, I always have my core and only give up the first few dollars and the purchase price of the options. Something to think about. Not for the timid, though. Volatility can be your best friend, believe it or not. The smartest post I’ve read in ages ...all good points, that’s how options should be used ..everyone’s afraid of missing out but if you can replace some of your shares for 1/4 the cost to give yourself peace of mind that you’re not gonna miss out, and then trade with your shares. You also don’t have the dead money issue when the stock stalls out. Which is actually risking less to make more. |
|
|
|
Post by letitride on Jan 10, 2020 22:27:58 GMT -5
The stock is going up because I Let it Ride.
Lets Go!
|
|
|
|
Post by mnkdfann on Jan 11, 2020 10:15:53 GMT -5
Looking at the six month chart, I see a similar spike in volume and price occurred 2 months ago, as well as two months before that.
What drove those spikes? (I don't recall, myself.) And will this one end differently? We'll see next week, I guess.
|
|
|
|
Post by MnkdWASmyRtrmntPlan on Jan 11, 2020 11:18:32 GMT -5
More investors are now doing what I have been doing for the last 5 years - buying and holding shares and ignoring all negativity along the way... Exactly what I have been doing, buyit. Except, I have stopped ignoring that negativity lately. Despite all my buying, I have done nothing but lose money so far (well, up to 5 months ago, when it bottomed out at $1.05). And, in consideration of all those continued loses, brought on a lot by the 1/5 reverse-split and continued dilution at small stock prices, I have lost confidence in our leader's decision-making and I am very tense going into this Annual Conf Call. I am scared not only for him doubling the number of shares available, but also for the resulting reverse-split that will probably be required when the SP crashes after that announcement. |
|
